Bionano Genomics announced upgrades to its pipeline for analysis of optical genome mapping – OGM – data in its VIA software for applications in constitutional genetic disease. The latest analysis pipeline, Bionano Solve 3.8.1, enhances the sensitivity and specificity for structural variation – SV – detection from OGM data, which, when combined with copy number variant – CNV – analysis capabilities introduced in July 2023, further advance OGM’s variant detection. Together with the enhanced performance for SV and CNV calling, VIA software now enables visualization, interpretation and reporting of SVs and CNVs from OGM data. Researchers can construct a report template with desired sample and variant information that is relevant for a particular study. Reports can then be automatically populated for each sample during the course of a research study. VIA software contains a knowledge base, which consists of a vault of previously curated variant interpretations. VIA software enables the integration of multiple data types, including chromosomal microarray analysis and next-generation sequencing, which can be visualized, interpreted and reported alongside OGM.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BNGO:
- Bionano Announces Significant Upgrades to its Bionano Solve Pipeline and its VIA™ Software for OGM Data Analysis in Constitutional Genetic Disease Research
- Bionano Genomics announces publication comparing OGM to CMA and KT
- Bionano Announces Publication of Largest Prospective Prenatal Study Comparing OGM to Chromosomal Microarray Analysis and Karyotyping
- Cancers Journal Publishes Special Issue Dedicated to OGM’s Impact on Hematological Malignancy Research
- Bionano Genomics reports special issue of Cancers journal dedicated to OGM